Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...

先進的な足腰力測定システムを開発している慶應義塾大学理工学部発スタートアップの株式会社AYUMI BIONICS（本社：東京都中央区、代表取締役田脇 裕太、以下 AYUMI BIONICS）は、このたび、第三者割当増資を実施し、シード期の資金調達を実施しました。

[Asia Economy Reporter Jang Hyowon] SL Bionics announced on the 14th that after completing the merger with the oil company Woosung Industry and establishing a new energy division, the company's ...